Wenhua Xiu

Title: The Innovations of Wenhua Xiu

Introduction

Wenhua Xiu is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for cancer treatment. His work is characterized by a focus on innovative compounds that target specific biological pathways.

Latest Patents

Wenhua Xiu holds 1 patent for his invention titled "Tricyclic derivatives inhibitor, preparation method, and applications thereof." This patent describes an inhibitor containing a tricyclic derivative, a preparation method for the inhibitor, and a pharmaceutical composition that includes the inhibitor. The invention is particularly relevant as it serves as a phosphoinositide 3 kinase (PI3K) inhibitor, which is crucial in the treatment of cancer and other diseases or conditions that are mediated by or dependent on PI3K imbalance.

Career Highlights

Throughout his career, Wenhua Xiu has worked with prominent companies in the pharmaceutical industry. He has been associated with Jiangsu Hansoh Pharmaceutical Group Co., Ltd. and Shanghai Hansoh Biomedical Co., Ltd. His experience in these organizations has allowed him to contribute to various innovative projects and advancements in drug development.

Collaborations

Wenhua Xiu has collaborated with several professionals in his field, including Peng Gao and Guangjun Sun. These collaborations have further enhanced his research and development efforts, leading to impactful innovations in pharmaceuticals.

Conclusion

Wenhua Xiu's contributions to the field of pharmaceuticals, particularly through his innovative patent on tricyclic derivatives, highlight his role as a significant inventor. His work continues to influence cancer treatment and the development of targeted therapies.